Publikationen von Luzia Berchtold
2025
- Steindl A., Zach C., Berchtold L., Grisold A., Gatterbauer B., Eckert F., Bago-Horvath Z., Hainfellner J.A., Exner R., Fitzal F., Pfeiler G., Singer C.F., Widhalm G., Bartsch R., Preusser M., Berghoff A.S.
Prognostic Relevance of the Neurological Symptom Burden in Brain Metastases from Breast Cancer.
British Journal of Cancer, (2025) [bib]
@ARTICLE{steindl2025prns, author = {Steindl, A.~ and Zach, C.~ and Berchtold, L.~ and Grisold, A.~ and Gatterbauer, B.~ and Eckert, F.~ and Bago-Horvath, Z.~ and Hainfellner, J.A.~ and Exner, R.~ and Fitzal, F.~ and Pfeiler, G.~ and Singer, C.F.~ and Widhalm, G.~ and Bartsch, R.~ and Preusser, M.~ and Berghoff, A.S.~}, title = {Prognostic Relevance of the Neurological Symptom Burden in Brain Metastases from Breast Cancer.}, journal = {British Journal of Cancer}, year = {2025}, doi = {10.1038/s41416-025-02967-w} } - Kleinberger M., Çifçi D., Paiato C., Tomasich E., Mair M.J., Steindl A., Spiró Z., Carrero Z.I., Berchtold L., Hainfellner J., Müllauer L., Heller G., Preusser M., Kather J.N., Berghoff A.S.
Density and Entropy of Immune Cells within the Tumor Microenvironment of Primary Tumors and Matched Brain Metastases.
Acta Neuropathologica Communications 13:34, (2025) [bib]
@ARTICLE{kleinberger2025deic34, author = {Kleinberger, M.~ and Çifçi, D.~ and Paiato, C.~ and Tomasich, E.~ and Mair, M.J.~ and Steindl, A.~ and Spiró, Z.~ and Carrero, Z.I.~ and Berchtold, L.~ and Hainfellner, J.~ and M{\"u}llauer, L.~ and Heller, G.~ and Preusser, M.~ and Kather, J.N.~ and Berghoff, A.S.~}, title = {Density and Entropy of Immune Cells within the Tumor Microenvironment of Primary Tumors and Matched Brain Metastases.}, journal = {Acta Neuropathologica Communications}, year = {2025}, volume = {13}, pages = {34}, issn = {2051-5960}, doi = {10.1186/s40478-025-01939-8}, keywords = {Adult;Female;Humans;Male;Retrospective Studies;Aged;Middle Aged;Entropy;*Brain Neoplasms/immunology/pathology/secondary;*Lymphocytes;Tumor-Infiltrating/pathology/immunology;*Tumor Microenvironment/immunology;Breast Neoplasms/pathology/immunology;Carcinoma;Non-Small-Cell Lung/pathology/immunology;Carcinoma;Renal Cell/pathology/immunology;Kidney Neoplasms/pathology/immunology;Lung Neoplasms/pathology/immunology;Tumor-Associated Macrophages/immunology/pathology} } - Geurts M., Berchtold L., Koenig F., Nabors B., Reardon D.A., Tonn J.C., Stupp R., Gorlia T., Weller M., Preusser M.
Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma in the CENTRIC EORTC 26071-22072 and CORE Trials: Does Time of Administration Matter?
Neuro-Oncology Practice 12(2), 291–300, (2025) [bib]
@ARTICLE{geurts2025tcpw291300, author = {Geurts, M.~ and Berchtold, L.~ and Koenig, F.~ and Nabors, B.~ and Reardon, D.A.~ and Tonn, J.C.~ and Stupp, R.~ and Gorlia, T.~ and Weller, M.~ and Preusser, M.~}, title = {Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma in the CENTRIC EORTC 26071-22072 and CORE Trials: Does Time of Administration Matter?}, journal = {Neuro-Oncology Practice}, year = {2025}, volume = {12}, number = {2}, pages = {291--300}, issn = {2054-2577 2054-2585}, doi = {10.1093/nop/npaf006}, keywords = {glioblastoma;chronotherapy;temozolomide} }
2024
- Bartsch R., Berghoff A.S., Furtner J., Marhold M., Bergen E.S., Roider-Schur S., Mair M.J., Starzer A.M., Forstner H., Rottenmanner B., Aretin M.-B., Dieckmann K., Bago-Horvath Z., Haslacher H., Widhalm G., Ilhan-Mutlu A., Minichsdorfer C., Fuereder T., Szekeres T., Oehler L., Gruenberger B., Pfeiler G., Singer C., Weltermann A., Berchtold L., Preusser M.
Final Outcome Analysis from the Phase II TUXEDO-1 Trial of Trastuzumab-Deruxtecan in HER2-Positive Breast Cancer Patients with Active Brain Metastases.
Neuro-Oncology 26(12), 2305–2315, (2024) [bib]
@ARTICLE{bartsch2024foap23052315, author = {Bartsch, R.~ and Berghoff, A.S.~ and Furtner, J.~ and Marhold, M.~ and Bergen, E.S.~ and Roider-Schur, S.~ and Mair, M.J.~ and Starzer, A.M.~ and Forstner, H.~ and Rottenmanner, B.~ and Aretin, M.-B.~ and Dieckmann, K.~ and Bago-Horvath, Z.~ and Haslacher, H.~ and Widhalm, G.~ and Ilhan-Mutlu, A.~ and Minichsdorfer, C.~ and Fuereder, T.~ and Szekeres, T.~ and Oehler, L.~ and Gruenberger, B.~ and Pfeiler, G.~ and Singer, C.~ and Weltermann, A.~ and Berchtold, L.~ and Preusser, M.~}, title = {Final Outcome Analysis from the Phase II TUXEDO-1 Trial of Trastuzumab-Deruxtecan in HER2-Positive Breast Cancer Patients with Active Brain Metastases.}, journal = {Neuro-Oncology}, year = {2024}, volume = {26}, number = {12}, pages = {2305--2315}, issn = {1523-5866 1522-8517}, doi = {10.1093/neuonc/noae123}, keywords = {breast cancer;Brain metastases;HER2-positive;trastuzumab deruxtecan} } - Melhorn P., Raderer M., Mazal P., Berchtold L., Beer L., Kiesewetter B.
Liver Metastases in High-Grade Neuroendocrine Neoplasms: A Comparative Study of Hepatic Tumor Volume and Biochemical Findings in NET G3 versus NEC.
Journal of Neuroendocrinology 36(12):e13454, (2024) [bib]
@ARTICLE{melhorn2024lmhne13454, author = {Melhorn, P.~ and Raderer, M.~ and Mazal, P.~ and Berchtold, L.~ and Beer, L.~ and Kiesewetter, B.~}, title = {Liver Metastases in High-Grade Neuroendocrine Neoplasms: A Comparative Study of Hepatic Tumor Volume and Biochemical Findings in NET G3 versus NEC.}, journal = {Journal of Neuroendocrinology}, year = {2024}, volume = {36}, number = {12}, pages = {e13454}, issn = {1365-2826 0953-8194}, doi = {10.1111/jne.13454}, keywords = {biochemistry;computed tomography;metastases;neuroendocrine carcinoma;neuroendocrine neoplasm} } - Geurts M., Berchtold L., Koenig F., Naburs B., Reardon D., Tonn J., Stupp R., Gorlia T., Weller M., Preusser M., EORTC Brain Tumor Group
Maintenance Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma: Does Time of Administration Matter?
Neuro-Oncology 26(Suppl 5: Abstracts 19th Meeting of the European Association of Neuro-Oncology, Glasgow, United Kingdom, 17–20 October 2024), V9, (2024) [bib]
@ARTICLE{geurts2024mtcpv9v9, author = {Geurts, M.~ and Berchtold, L.~ and Koenig, F.~ and Naburs, B.~ and Reardon, D.~ and Tonn, J.~ and Stupp, R.~ and Gorlia, T.~ and Weller, M.~ and Preusser, M.~ and {EORTC Brain Tumor Group}}, title = {Maintenance Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma: Does Time of Administration Matter?}, journal = {Neuro-Oncology}, year = {2024}, volume = {26}, number = {Suppl 5: Abstracts 19th Meeting of the European Association of Neuro-Oncology, Glasgow, United Kingdom, 17–20 October 2024}, pages = {V9}, issn = {1522-8517}, doi = {10.1093/neuonc/noae144.023} } - Ilhan-Mutlu A., Puhr H.C., Berchtold L., Zingerle L., Felfernig M., Weissenbacher L., Jomrich G., Asari R., Schoppmann S.F., Prager G.W., Bergen E.S., Berghoff A.S., Preusser M.
Association of Family History with Patient Characteristics and Prognosis in a Large European Gastroesophageal Cancer Cohort.
Wiener Klinische Wochenschrift, (2024) [bib]
@ARTICLE{ilhanmutlu2024afhw, author = {Ilhan-Mutlu, A.~ and Puhr, H.C.~ and Berchtold, L.~ and Zingerle, L.~ and Felfernig, M.~ and Weissenbacher, L.~ and Jomrich, G.~ and Asari, R.~ and Schoppmann, S.F.~ and Prager, G.W.~ and Bergen, E.S.~ and Berghoff, A.S.~ and Preusser, M.~}, title = {Association of Family History with Patient Characteristics and Prognosis in a Large European Gastroesophageal Cancer Cohort.}, journal = {Wiener Klinische Wochenschrift}, year = {2024}, doi = {10.1007/s00508-024-02432-3} } - Kleinberger M., Cifci D., Paiato C., Tomasich E., Mair M., Steindl A., Carrero Z., Berchtold L., Hainfellner J., Müllauer L., Heller G., Preusser M., Kather J., Berghoff A.
Characterization of Tumor-Infiltrating Lymphocytes and Tumor-Associated Macrophages Within the Tumor Microenvironment of Primary Tumors and Matched Brain Metastases.
Annals of Oncology 35(Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024), S409–S410, (2024) [bib]
@ARTICLE{kleinberger2024ctlts409s410, author = {Kleinberger, M.~ and Cifci, D.~ and Paiato, C.~ and Tomasich, E.~ and Mair, M.~ and Steindl, A.~ and Carrero, Z.~ and Berchtold, L.~ and Hainfellner, J.~ and M{\"u}llauer, L.~ and Heller, G.~ and Preusser, M.~ and Kather, J.~ and Berghoff, A.~}, title = {Characterization of Tumor-Infiltrating Lymphocytes and Tumor-Associated Macrophages Within the Tumor Microenvironment of Primary Tumors and Matched Brain Metastases.}, journal = {Annals of Oncology}, year = {2024}, volume = {35}, number = {Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024}, pages = {S409--S410}, issn = {0923-7534}, doi = {10.1016/j.annonc.2024.08.520} } - Fuereder T., Klinghammer K., Hahn D.A., Grünberger B., Melchardt T., Greil R., Kocher F., Gamerith G., Wagner C., Berchtold L., Burian M., Strobl A.
Paclitaxel Plus Cetuximab for the Treatment of Recurrent and/or Metastatic Head and Neck Cancer after First-Line Checkpoint Inhibitor Failure: Primary Analysis from the Pace Ace Trial.
Annals of Oncology 35(Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024), S629, (2024) [bib]
@ARTICLE{fuereder2024ppcts629s629, author = {Fuereder, T.~ and Klinghammer, K.~ and Hahn, D.A.~ and Gr{\"u}nberger, B.~ and Melchardt, T.~ and Greil, R.~ and Kocher, F.~ and Gamerith, G.~ and Wagner, C.~ and Berchtold, L.~ and Burian, M.~ and Strobl, A.~}, title = {Paclitaxel Plus Cetuximab for the Treatment of Recurrent and/or Metastatic Head and Neck Cancer after First-Line Checkpoint Inhibitor Failure: Primary Analysis from the Pace Ace Trial.}, journal = {Annals of Oncology}, year = {2024}, volume = {35}, number = {Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024}, pages = {S629}, issn = {0923-7534}, doi = {10.1016/j.annonc.2024.08.941}, url = {https://www.sciencedirect.com/science/article/pii/S0923753424024608} } - Gottmann L., Kleinberger M., Fuerst J., Korpan M., Berger J., Sunder-Plassmann V., Englisch C., Vladic N., Berchtold L., Henao I., Göksun M., Puhr H., Starzer A., Mair M., Furtner J., Bergen E., Berghoff A., Preusser M.
Significance of Skeletal Muscle Measurement in Cancer-Associated Cachexia Screening.
Annals of Oncology 35(Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024), S1081, (2024) [bib]
@ARTICLE{gottmann2024ssmms1081s1081, author = {Gottmann, L.~ and Kleinberger, M.~ and Fuerst, J.~ and Korpan, M.~ and Berger, J.~ and Sunder-Plassmann, V.~ and Englisch, C.~ and Vladic, N.~ and Berchtold, L.~ and Henao, I.~ and G{\"o}ksun, M.~ and Puhr, H.~ and Starzer, A.~ and Mair, M.~ and Furtner, J.~ and Bergen, E.~ and Berghoff, A.~ and Preusser, M.~}, title = {Significance of Skeletal Muscle Measurement in Cancer-Associated Cachexia Screening.}, journal = {Annals of Oncology}, year = {2024}, volume = {35}, number = {Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024}, pages = {S1081}, issn = {0923-7534}, doi = {10.1016/j.annonc.2024.08.1919} } - Berghoff A., Huber D., Berchtold L., Sunder-Plassmann B., Berger J., Gottmann L., Korpan M., Kleinberger M., Fürst J., Vladic N., Sunder-Plassmann V., Göksun M., Englisch C., Starzer A., Preusser M.
Feasibility of Wrist-Worn Health-Tracker Data to Predict the Need for Therapy Modifications in Patients with Metastatic Cancer.
Annals of Oncology 35(Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024), S1087–S1088, (2024) [bib]
@ARTICLE{berghoff2024fwhds1087s1088, author = {Berghoff, A.~ and Huber, D.~ and Berchtold, L.~ and Sunder-Plassmann, B.~ and Berger, J.~ and Gottmann, L.~ and Korpan, M.~ and Kleinberger, M.~ and F{\"u}rst, J.~ and Vladic, N.~ and Sunder-Plassmann, V.~ and G{\"o}ksun, M.~ and Englisch, C.~ and Starzer, A.~ and Preusser, M.~}, title = {Feasibility of Wrist-Worn Health-Tracker Data to Predict the Need for Therapy Modifications in Patients with Metastatic Cancer.}, journal = {Annals of Oncology}, year = {2024}, volume = {35}, number = {Suppl 2: Abstract Book of the ESMO Congress 2024, Barcelona, Spain,13-17 September 2024}, pages = {S1087--S1088}, issn = {0923-7534}, doi = {10.1016/j.annonc.2024.08.1936} } - Tomasich E., Mühlbacher J., Wöran K., Hatziioannou T., Herac M., Kleinberger M., Berger J.M., Dibon L.K., Berchtold L., Heller G., Bergen E.S., Macher-Beer A., Prager G., Schindl M., Preusser M., Berghoff A.S.
Immune Cell Distribution and DNA Methylation Signatures Differ between Tumor and Stroma Enriched Compartment in Pancreatic Ductal Adenocarcinoma.
Translational Research 271, 40–51, (2024) [bib]
@ARTICLE{tomasich2024icdd4051, author = {Tomasich, E.~ and M{\"u}hlbacher, J.~ and W{\"o}ran, K.~ and Hatziioannou, T.~ and Herac, M.~ and Kleinberger, M.~ and Berger, J.M.~ and Dibon, L.K.~ and Berchtold, L.~ and Heller, G.~ and Bergen, E.S.~ and Macher-Beer, A.~ and Prager, G.~ and Schindl, M.~ and Preusser, M.~ and Berghoff, A.S.~}, title = {Immune Cell Distribution and DNA Methylation Signatures Differ between Tumor and Stroma Enriched Compartment in Pancreatic Ductal Adenocarcinoma.}, journal = {Translational Research}, year = {2024}, volume = {271}, pages = {40--51}, doi = {10.1016/j.trsl.2024.05.005}, url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85193449230\&doi=10.1016%2fj.trsl.2024.05.005\&partnerID=40\&md5=e865208f1af41b9251650dc4dc57846f} } - Puhr H., Berchtold L., Zingerle L., Korpan M., Berger J., Jomrich G., Asari R., Schoppmann S., Prager G., Bergen E., Berghoff A., Preusser M., Ilhan-Mutlu A.
Association of Prior and Concurrent Malignancies with Overall Survival in a Large European Single-Center Gastroesophageal Cancer Cohort.
Annals of Oncology 35(Suppl 1: Abstract Book of the European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress 2024, Munich, Germany, 26–29 June 2024), S187, (2024) [bib]
@ARTICLE{puhr2024apcms187s187, author = {Puhr, H.~ and Berchtold, L.~ and Zingerle, L.~ and Korpan, M.~ and Berger, J.~ and Jomrich, G.~ and Asari, R.~ and Schoppmann, S.~ and Prager, G.~ and Bergen, E.~ and Berghoff, A.~ and Preusser, M.~ and Ilhan-Mutlu, A.~}, title = {Association of Prior and Concurrent Malignancies with Overall Survival in a Large European Single-Center Gastroesophageal Cancer Cohort.}, journal = {Annals of Oncology}, year = {2024}, volume = {35}, number = {Suppl 1: Abstract Book of the European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress 2024, Munich, Germany, 26–29 June 2024}, pages = {S187}, issn = {0923-7534}, doi = {10.1016/j.annonc.2024.05.380} }
2023
- Berger J.M., Alany A., Berchtold L., Puhr R., Friedrich A., Scheiner B., Prager G.W., Preusser M., Berghoff A.S., Bergen E.S.
Prognosticators of Survival in Patients with Metastatic Pancreatic Cancer and Ascites.
ESMO Open 8(6):102048, (2023) [bib]
@ARTICLE{berger2023pspw102048, author = {Berger, J.M.~ and Alany, A.~ and Berchtold, L.~ and Puhr, R.~ and Friedrich, A.~ and Scheiner, B.~ and Prager, G.W.~ and Preusser, M.~ and Berghoff, A.S.~ and Bergen, E.S.~}, title = {Prognosticators of Survival in Patients with Metastatic Pancreatic Cancer and Ascites.}, journal = {ESMO Open}, year = {2023}, volume = {8}, number = {6}, pages = {102048}, doi = {10.1016/j.esmoop.2023.102048}, url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85178970195\&doi=10.1016%2fj.esmoop.2023.102048\&partnerID=40\&md5=489421f42d413b1832076cfcf2201fb7} } - Tomasich E., Steindl A., Paiato C., Hatziioannou T., Kleinberger M., Berchtold L., Puhr R., Hainfellner J.A., Müllauer L., Widhalm G., Eckert F., Bartsch R., Heller G., Preusser M., Berghoff A.S.
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.
Clinical Cancer Research 29(16), 3225–3236, (2023) [bib]
@ARTICLE{tomasich2023fohb32253236, author = {Tomasich, E.~ and Steindl, A.~ and Paiato, C.~ and Hatziioannou, T.~ and Kleinberger, M.~ and Berchtold, L.~ and Puhr, R.~ and Hainfellner, J.A.~ and M{\"u}llauer, L.~ and Widhalm, G.~ and Eckert, F.~ and Bartsch, R.~ and Heller, G.~ and Preusser, M.~ and Berghoff, A.S.~}, title = {Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.}, journal = {Clinical Cancer Research}, year = {2023}, volume = { 29}, number = {16}, pages = {3225--3236}, issn = {1557-3265 1078-0432}, doi = {10.1158/1078-0432.CCR-23-0020} } - Mair M.J., Mitterer M., Buratti T., Berchtold L., Fong D., Preusser M.
Timely Course of SARS-CoV-2 Infections and Vaccinations in Patients with Hemato-Oncological Diseases: Analysis of a Real-Life Cohort.
ESMO Open 8(3):101559, (2023) [bib]
@ARTICLE{mair2023tcsi101559, author = {Mair, M.J.~ and Mitterer, M.~ and Buratti, T.~ and Berchtold, L.~ and Fong, D.~ and Preusser, M.~}, title = {Timely Course of SARS-CoV-2 Infections and Vaccinations in Patients with Hemato-Oncological Diseases: Analysis of a Real-Life Cohort.}, journal = {ESMO Open}, year = {2023}, volume = {8}, number = {3}, pages = {101559}, doi = {10.1016/j.esmoop.2023.101559}, url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85159157757\&doi=10.1016%2fj.esmoop.2023.101559\&partnerID=40\&md5=2a7f5cbf763dc4acee87077c93dc52ae} } - Berger J.M., Alany A., Puhr R., Berchtold L., Friedrich A., Scheiner B., Prager G.W., Berghoff A.S., Preusser M., Bergen E.S.
Clinical Risk Factors for Ascites in Metastatic Pancreatic Cancer.
ESMO Open 8(2):101200, (2023) [bib]
@ARTICLE{berger2023crfa101200, author = {Berger, J.M.~ and Alany, A.~ and Puhr, R.~ and Berchtold, L.~ and Friedrich, A.~ and Scheiner, B.~ and Prager, G.W.~ and Berghoff, A.S.~ and Preusser, M.~ and Bergen, E.S.~}, title = {Clinical Risk Factors for Ascites in Metastatic Pancreatic Cancer.}, journal = {ESMO Open}, year = {2023}, volume = {8}, number = {2}, pages = {101200}, issn = {2059-7029}, doi = {10.1016/j.esmoop.2023.101200}, keywords = {Female;Humans;Male;Retrospective Studies;Risk Factors;Inflammation/complications;systemic inflammation;peritoneal carcinomatosis;*Ascites/etiology/epidemiology/pathology;*Pancreatic Neoplasms/drug therapy;ascites;liver metastases;metastatic pancreatic cancer} }